Related Experiment Video
Updated: Jan 21, 2026
07:10
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
10.3K
Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers
Mario Cazzola1, Ermanno Puxeddu2, Josuel Ora2
1Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy. mario.cazzola@uniroma2.it.
Molecular Diagnosis & Therapy
|August 1, 2019
Summary
Blood biomarkers show promise for chronic obstructive pulmonary disease (COPD), but none are accurate enough for diagnosis or progression. Combinations may offer insights, but further research is needed.
Area of Science:
- Pulmonary Medicine
- Biomarker Research
- Diagnostic Accuracy
Background:
- Growing interest in blood-based biomarkers for chronic obstructive pulmonary disease (COPD) clinical application.
- Existing biomarker panels show statistical associations with COPD but lack diagnostic accuracy.
- Many current biomarkers are non-specific, indicating general inflammation or other chronic conditions.
Purpose of the Study:
- To review the current status of blood-based biomarkers for COPD diagnosis and progression.
- To evaluate the clinical utility and limitations of individual and combined biomarkers.
- To identify remaining challenges in COPD biomarker research.
Main Methods:
- Literature review of studies on blood-based biomarkers in COPD.
- Analysis of biomarker associations with COPD diagnosis, progression, and specificity.
- Evaluation of the potential of combined biomarker panels.
Main Results:
- No single blood biomarker currently meets the accuracy criteria for clinical COPD diagnosis or progression monitoring.
- Biomarkers like interleukin-6 and soluble receptor for advanced glycation endproducts (sRAGE) are associated with inflammation and other diseases, limiting COPD specificity.
- Statistically significant associations exist between some biomarker panels and COPD, suggesting potential utility.
Conclusions:
- Blood-based biomarkers for COPD diagnosis and progression remain elusive despite significant research.
- Combinations of biomarkers may hold future diagnostic or prognostic value, but require careful interpretation.
- Further research is essential to address unanswered questions and validate biomarkers for clinical use in COPD management.
Related Concept Videos
01:22Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.3K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.1K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.6K